Use of peak oxygen consumption in predicting physical function and quality of life in COPD patients

Chest. 2006 Jun;129(6):1516-22. doi: 10.1378/chest.129.6.1516.

Abstract

Objective: To determine whether peak oxygen consumption (Vo(2)peak) adds to the power of FEV(1) in predicting physical function and quality of life in COPD patients.

Design: Single-center cross-sectional study.

Methods: Subjects included 291 COPD patients who completed pulmonary function testing, a graded exercise test, a 6-min walk, and stair climb test to assess physical function; a questionnaire assessing self-reported physical function; and a disease-specific, health-related quality-of-life questionnaire. Hierarchical multiple regression analysis was used to determine the contribution of Vo(2)peak in predicting physical function and quality of life after accounting for FEV(1).

Results: After accounting for FEV(1), Vo(2)peak added significantly to the prediction of 6-min walk distance (R(2) increased by 0.395 [p < 0.005]); stair climb time (R(2) increased by 0.262 [p < 0.005]); self-reported function (R(2) increased by 0.109 [p < 0.005]); and health-related quality-of-life domain of mastery (R(2) increased by 0.044 [p < 0.005]). Only Vo(2)peak was found to significantly predict the health-related quality-of-life domain of fatigue (R(2) = 0.094 [p < 0.005]).

Conclusion: After controlling for FEV(1), Vo(2)peak adds significantly to the prediction of physical function and health-related quality-of-life domain of mastery in COPD patients. These results provide additional support for the use of Vo(2)peak in the multidimensional assessment of COPD patients.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Activities of Daily Living*
  • Aged
  • Cross-Sectional Studies
  • Exercise Test
  • Female
  • Forced Expiratory Volume
  • Health Status*
  • Humans
  • Male
  • Middle Aged
  • Oxygen Consumption / physiology*
  • Predictive Value of Tests
  • Pulmonary Disease, Chronic Obstructive / metabolism*
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Quality of Life*